Resources

Relevant, timely and evidence-based information for Australian health professionals and consumers.

We have many resources available for consumers and health professionals including brochures, fact sheets and translated resources. All of our products are available free of charge.

Corporate documents

Corporate documents

Annual reports, budgets, corporate plans, reports

Clinical resources

Clinical resources

Fact sheets, action plans, brochures, guidelines, and more for health professionals and consumers

Multimedia

Multimedia

Videos, podcasts, conference recordings, images and Infographics

 

Filter

Sort by:
Lagevrio for COVID-19 Lagevrio for COVID-19

Lagevrio for COVID-19

  • 12 May 2022
  • Aboriginal and Torres Strait Islander resources

Lagevrio for COVID-19

  • 12 May 2022
  • Aboriginal and Torres Strait Islander resources
An introduction to managing asthma and wheeze in children under 6 An introduction to managing asthma and wheeze in children under 6

An introduction to managing asthma and wheeze in children under 6

  • 28 April 2020
  • Fact sheets and FAQs

An introduction to managing asthma and wheeze in children under 6

  • 28 April 2020
  • Fact sheets and FAQs
Fact sheet: Treating plaque psoriasis Fact sheet: Treating plaque psoriasis

Fact sheet: Treating plaque psoriasis

  • 13 August 2021
  • Fact sheets and FAQs

Fact sheet: Treating plaque psoriasis

  • 13 August 2021
  • Fact sheets and FAQs
Action plan: Low-dose methotrexate ​for rheumatoid arthritis and psoriatic arthritis Action plan: Low-dose methotrexate ​for rheumatoid arthritis and psoriatic arthritis

Action plan: Low-dose methotrexate ​for rheumatoid arthritis and psoriatic arthritis

  • 9 June 2021
  • Patient action plans

Action plan: Low-dose methotrexate ​for rheumatoid arthritis and psoriatic arthritis

  • 9 June 2021
  • Patient action plans
NPS MedicineWise Economic evaluation report Chronic pain report: Opioids and beyond 2015 NPS MedicineWise Economic evaluation report Chronic pain report: Opioids and beyond 2015

NPS MedicineWise Economic evaluation report Chronic pain report: Opioids and beyond 2015

  • 30 June 2020
  • Evaluation report

NPS MedicineWise Economic evaluation report Chronic pain report: Opioids and beyond 2015

  • 30 June 2020
  • Evaluation report
NPS MedicineWise Economic evaluation report Balancing benefits and harms of antipsychotic therapy 2015 NPS MedicineWise Economic evaluation report Balancing benefits and harms of antipsychotic therapy 2015

NPS MedicineWise Economic evaluation report Balancing benefits and harms of antipsychotic therapy 2015

  • 30 June 2020
  • Evaluation report

NPS MedicineWise Economic evaluation report Balancing benefits and harms of antipsychotic therapy 2015

  • 30 June 2020
  • Evaluation report
Reducing anticholinergic burden: Framework for action Reducing anticholinergic burden: Framework for action

Reducing anticholinergic burden: Framework for action

  • 1 December 2021
  • Clinical algorithms and tools

Reducing anticholinergic burden: Framework for action

  • 1 December 2021
  • Clinical algorithms and tools
Low-dose methotrexate ​for rheumatoid arthritis and psoriatic arthritis Low-dose methotrexate ​for rheumatoid arthritis and psoriatic arthritis

Low-dose methotrexate ​for rheumatoid arthritis and psoriatic arthritis

  • 9 June 2021
  • Fact sheets and FAQs

Low-dose methotrexate ​for rheumatoid arthritis and psoriatic arthritis

  • 9 June 2021
  • Fact sheets and FAQs
Farsi: Home medicines review factsheet Farsi: Home medicines review factsheet

Farsi: Home medicines review factsheet

  • 20 December 2021
  • Translated fact sheets

Farsi: Home medicines review factsheet

  • 20 December 2021
  • Translated fact sheets
Chinese (traditional): Home medicines review factsheet Chinese (traditional): Home medicines review factsheet

Chinese (traditional): Home medicines review factsheet

  • 20 December 2021
  • Translated fact sheets

Chinese (traditional): Home medicines review factsheet

  • 20 December 2021
  • Translated fact sheets